Geron (GERN) Total Non-Current Liabilities (2012 - 2026)

Geron's (GERN) quarterly Total Non-Current Liabilities came in at $194.6 million in Q1 2026, up 5.87% year-on-year from $183.8 million in Q1 2025, and down 16.3% quarter-over-quarter from $232.5 million in Q4 2025.

Geron (GERN) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Geron has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $194.6 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $194.6 million, up 5.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $194.6 million (up 5.87% YoY), and the FY2025 annual result was $232.5 million, up 11.24% from the prior year.
  • Total Non-Current Liabilities came in at $194.6 million for Q1 2026 at Geron, down from $232.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $232.5 million in Q4 2025 to a low of $183.8 million in Q1 2025.
  • The 3-year median for Total Non-Current Liabilities is $201.6 million (2025), against an average of $202.3 million.
  • Across the five-year window, Total Non-Current Liabilities advanced 11.24% in 2025 and increased 5.87% in 2026, its largest moves.
  • Geron's Total Non-Current Liabilities stood at $209.0 million in 2024, then advanced by 11.24% to $232.5 million in 2025, then retreated by 16.3% to $194.6 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $194.6 million (Q1 2026), $232.5 million (Q4 2025), and $208.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 42,980.09
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 11.03 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.71 Bn 91.71 Bn - 64.76 Mn
10 Geron 729,618.77 729,618.77 - 194.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 194.63 Mn
Dec 31, 2025 232.53 Mn
Sep 30, 2025 208.63 Mn
Jun 30, 2025 185.14 Mn
Mar 31, 2025 183.83 Mn
Dec 31, 2024 209.04 Mn
Dec 31, 2014 41.78 Mn
Sep 30, 2014 7.07 Mn
Jun 30, 2014 4.47 Mn
Mar 31, 2014 4.37 Mn
Dec 31, 2013 7.22 Mn
Sep 30, 2013 6.58 Mn
Jun 30, 2013 4.95 Mn
Mar 31, 2013 6.77 Mn
Dec 31, 2012 14.10 Mn